Q4 2022 Holdings
Filed 2023-02-14 | 42 holdings | $510.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $38.4M | 800,000 | 7.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $33.5M | 850,000 | 6.6% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $28.4M | 1,436,569 | 5.6% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $26.7M | 3,637,718 | 5.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $25.6M | 1,322,870 | 5.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $25.5M | 160,000 | 5.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $20.6M | 160,500 | 4.0% |
| Point Biopharma Global Inc | COM | 730541109 | $18.5M | 2,541,779 | 3.6% |
| Novocure LTD(NVCR)Put | ORD SHS | G6674U108 | $17.7M | 241,000 | 3.5% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $17.7M | 825,000 | 3.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $16.1M | 1,019,282 | 3.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $15.9M | 6,360,161 | 3.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $15.9M | 342,300 | 3.1% |
| Optinose Inc | COM | 68404V100 | $14.6M | 7,894,736 | 2.9% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $13.1M | 400,695 | 2.6% |
| Cincor Pharma Inc | COM | 17240Y109 | $12.5M | 1,019,153 | 2.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $12.2M | 1,295,034 | 2.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $11.7M | 544,451 | 2.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $11.5M | 302,135 | 2.3% |
| Aerovate Therapeutics Inc | COM | 008064107 | $11.1M | 378,522 | 2.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $10.0M | 475,000 | 2.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $9.7M | 1,550,000 | 1.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.5M | 73,000 | 1.9% |
| Rocket Pharmaceuticals Inc(RCKT)Call | COM | 77313F106 | $8.8M | 451,000 | 1.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.1M | 1,055,801 | 1.4% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.0M | 190,000 | 1.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $6.7M | 642,566 | 1.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $6.6M | 1,538,461 | 1.3% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $6.5M | 528,850 | 1.3% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $6.0M | 1,116,581 | 1.2% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $6.0M | 133,000 | 1.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.8M | 300,000 | 1.1% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $5.8M | 267,283 | 1.1% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $5.3M | 1,273,635 | 1.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $5.0M | 560,000 | 1.0% |
| Precision Biosciences Inc | COM | 74019P108 | $4.5M | 3,801,305 | 0.9% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $4.5M | 1,962,399 | 0.9% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $4.0M | 1,022,537 | 0.8% |
| Evolus Inc(EOLS) | COM | 30052C107 | $1.4M | 190,329 | 0.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.2M | 46,185 | 0.2% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $885.1K | 632,184 | 0.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $464.9K | 15,000 | 0.1% |